INdermal

About Nanovex Biotechnologies

Nanovex Biotechnologies operates as a specialized service provider and technology developer in the nanobiotechnology space, focusing on advanced drug delivery systems. Its core business model involves offering customized formulation, development, and manufacturing services for nanocarriers, acting as an extension of clients' R&D departments. The company targets challenges in pharmaceutical development such as poor solubility, toxicity, and low efficacy, while also having a cosmetic brand, INdermal, for skin applications. It is a private, likely pre-revenue or early-revenue entity, supporting partners from proof-of-concept through to prototype manufacturing.